Barbara Mania‐Farnell

1.4k total citations
37 papers, 1.1k citations indexed

About

Barbara Mania‐Farnell is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Barbara Mania‐Farnell has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Barbara Mania‐Farnell's work include Glioma Diagnosis and Treatment (9 papers), Epigenetics and DNA Methylation (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Barbara Mania‐Farnell is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), Epigenetics and DNA Methylation (7 papers) and Glycosylation and Glycoproteins Research (5 papers). Barbara Mania‐Farnell collaborates with scholars based in United States, Japan and South Korea. Barbara Mania‐Farnell's co-authors include Chandra S. Mayanil, David George, Tadanori Tomita, E. Bremer, David G. McLone, Emmanuelle J. Meuillet, Shunsuke Ichi, Guifa Xi, Hirotaka Yamamoto and Vanda Boshnjaku and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and FEBS Letters.

In The Last Decade

Barbara Mania‐Farnell

37 papers receiving 1.1k citations

Peers

Barbara Mania‐Farnell
Chandra S. Mayanil United States
Li‐Wei Chang United States
Heechul Kim South Korea
Radhika Iyer United States
Keren Ziv Israel
Julia Billiard United States
Rebecca Stockton United States
Chandra S. Mayanil United States
Barbara Mania‐Farnell
Citations per year, relative to Barbara Mania‐Farnell Barbara Mania‐Farnell (= 1×) peers Chandra S. Mayanil

Countries citing papers authored by Barbara Mania‐Farnell

Since Specialization
Citations

This map shows the geographic impact of Barbara Mania‐Farnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Mania‐Farnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Mania‐Farnell more than expected).

Fields of papers citing papers by Barbara Mania‐Farnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Mania‐Farnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Mania‐Farnell. The network helps show where Barbara Mania‐Farnell may publish in the future.

Co-authorship network of co-authors of Barbara Mania‐Farnell

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Mania‐Farnell. A scholar is included among the top collaborators of Barbara Mania‐Farnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Mania‐Farnell. Barbara Mania‐Farnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wadhwani, Nitin R., Sonali Nayak, Yu‐Fen Wang, et al.. (2023). WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. Cancers. 15(13). 3429–3429. 2 indexed citations
2.
Nayak, Sonali, Yongyong Yang, Mark McClendon, et al.. (2020). Bone Morphogenetic Protein 4 Targeting Glioma Stem-Like Cells for Malignant Glioma Treatment: Latest Advances and Implications for Clinical Application. Cancers. 12(2). 516–516. 16 indexed citations
3.
Xi, Guifa, Gordan Grahovac, Veena Rajaram, et al.. (2017). Targeting CD133 improves chemotherapeutic efficacy of recurrent pediatric pilocytic astrocytoma following prolonged chemotherapy. Molecular Cancer. 16(1). 21–21. 20 indexed citations
4.
Xi, Guifa, Erik Robinson, Barbara Mania‐Farnell, et al.. (2013). Convection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatment. Nanomedicine Nanotechnology Biology and Medicine. 10(2). 381–391. 115 indexed citations
5.
Boshnjaku, Vanda, Kyu‐Won Shim, Takao Tsurubuchi, et al.. (2012). Nuclear localization of folate receptor alpha: a new role as a transcription factor. Scientific Reports. 2(1). 980–980. 81 indexed citations
6.
Ichi, Shunsuke, Vanda Boshnjaku, Barbara Mania‐Farnell, et al.. (2011). Fetal Neural Tube Stem Cells from Pax3 Mutant Mice Proliferate, Differentiate, and Form Synaptic Connections When Stimulated with Folic Acid. Stem Cells and Development. 21(2). 321–330. 28 indexed citations
7.
Ichi, Shunsuke, Vanda Boshnjaku, Barbara Mania‐Farnell, et al.. (2010). Role of Pax3 acetylation in the regulation ofHes1andNeurog2. Molecular Biology of the Cell. 22(4). 503–512. 42 indexed citations
8.
Ichi, Shunsuke, Fabrício F. Costa, Jared M. Bischof, et al.. (2010). Folic Acid Remodels Chromatin on Hes1 and Neurog2 Promoters during Caudal Neural Tube Development. Journal of Biological Chemistry. 285(47). 36922–36932. 74 indexed citations
9.
Mania‐Farnell, Barbara, Shunsuke Ichi, Christopher J. McCabe, et al.. (2008). Key basic helix–loop–helix transcription factor genes Hes1 and Ngn2 are regulated by Pax3 during mouse embryonic development. Developmental Biology. 316(2). 510–523. 59 indexed citations
10.
Mayanil, Chandra S., Barbara Mania‐Farnell, Beth Yun, et al.. (2006). Regulation of Murine TGFβ2 by Pax3 during Early Embryonic Development. Journal of Biological Chemistry. 281(34). 24544–24552. 29 indexed citations
11.
Mania‐Farnell, Barbara, et al.. (2002). Mentoring Students in an Introductory Science Course: Improvements in Grades and Course Retention.. The journal of college science teaching. 32(3). 5 indexed citations
12.
Miljan, Erik, Emmanuelle J. Meuillet, Barbara Mania‐Farnell, et al.. (2002). Interaction of the Extracellular Domain of the Epidermal Growth Factor Receptor with Gangliosides. Journal of Biological Chemistry. 277(12). 10108–10113. 147 indexed citations
13.
Meuillet, Emmanuelle J., Barbara Mania‐Farnell, David George, Jin‐ichi Inokuchi, & E. Bremer. (2000). Modulation of EGF Receptor Activity by Changes in the GM3 Content in a Human Epidermoid Carcinoma Cell Line, A431. Experimental Cell Research. 256(1). 74–82. 55 indexed citations
14.
Mayanil, Chandra S., et al.. (2000). Overexpression of Murine Pax3 Increases NCAM Polysialylation in a Human Medulloblastoma Cell Line. Journal of Biological Chemistry. 275(30). 23259–23266. 40 indexed citations
15.
Mania‐Farnell, Barbara & Thomas P. Davis. (1996). Modulation of Prohormone Convertase mRNA by Second Messenger Activators and Drugs. Annals of the New York Academy of Sciences. 780(1). 134–144. 3 indexed citations
16.
Mania‐Farnell, Barbara, Ihab W. Botros, Richard O. Day, & Thomas P. Davis. (1996). Differential modulation of prohormone convertase mRNA by second messenger activators in two cholecystokinin-producing cell lines. Peptides. 17(1). 47–54. 15 indexed citations
17.
Mania‐Farnell, Barbara, Ihab W. Botros, & Thomas P. Davis. (1995). Modulation of CCK mRNA in cell lines in response to isoproterenol and retinoic acid. Neuropeptides. 29(4). 221–227. 1 indexed citations
18.
Konings, Pierre N.M., Barbara Mania‐Farnell, Margery C. Beinfeld, et al.. (1993). Processing, release and metabolism of cholecystokinin in SK-N-MCIXC cells. Neuropeptides. 25(1). 19–30. 8 indexed citations
19.
Mania‐Farnell, Barbara, A.I. Farbman, & Richard C. Bruch. (1993). Bromocriptine, a dopamine d2 receptor agonist, inhibits adenylyl cyclase activity in rat olfactory epithelium. Neuroscience. 57(1). 173–180. 27 indexed citations
20.
Mania‐Farnell, Barbara, Bradley J. Merrill, Pierre N.M. Konings, & Thomas P. Davis. (1993). Regulation of CCK mRNA in the human neuroepithelioma cell line SK‐N‐MCIXC in response to second messenger activators. FEBS Letters. 335(1). 65–68. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026